Qiaoyong Yi

ORCID：0009-0000-7551-6966

发表论文 16 篇 · 总被引 85 次 · h-index 3

代表论文

• Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases (2018 · Cellular Physiology and Biochemistry · 被引 58)
• Triple knockdown of CD11a , CD49d , and PSGL1 in T cells reduces CAR-T cell toxicity but preserves activity against solid tumors in mice (2025 · Science Translational Medicine · 被引 14)
• Overexpression of the galectin-3 during tumor progression in prostate cancer and its clinical implications. (2018 · PubMed · 被引 9)
• Preclinical Development and a Case Report of a Nanobody-Based CLDN18.2 CAR-T IMC002 with Reduced On-Target Off-Tumor Toxicity (2025 · Molecular Cancer Therapeutics · 被引 2)
• IMV101, a novel CD19-targeted In Vivo CAR T therapy exhibits potent efficacy and tolerable safety profiles in preclinical models (2025 · Blood · 被引 2)
• Figure S3 from Preclinical Development and a Case Report of a Nanobody-Based CLDN18.2 CAR-T IMC002 with Reduced On-Target Off-Tumor Toxicity (2026)